http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9602269-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38ec8c49ce1122e1361ab404050fe915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5012d58bb33dc9709ccad873df226cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97405158b2766db5472bd7755dc4f90f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
filingDate 1995-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24310eda345ea37881734b7d421fbaa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97dfd15a46b25769aa5064599a50020b
publicationDate 1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9602269-A1
titleOfInvention Therapeutic method and compounds of use therein
abstract The use of amylin as an agent for stimulation of bone growth is provided together with methods of stimulating bone growth comprising subjecting bone to an effective amount of amylin or amylin agonists. Medicaments containing amylin or an amylin agonist are provided. The amylin or amylin agonist is preferably in the form in which the presence of TFA is minimised or totally removed. Preferably a salt with an inert anion is used. The method will be particularly useful in treating bone disorders where stimulation of bone growth is required. The treatment of osteoporosis, bone loss of malignancy, or endocrine disorders or arthritides or immobility and disuse and in fractures are examples of the many disorders which may be treated. Previous bone loss can be reversed, and bone density can be increased or maintained.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916406-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0904094-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916406-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6821954-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0904094-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208468-B2
priorityDate 1994-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5405831-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8802863-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128383593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127869814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128791547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129452469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128415257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102424

Total number of triples: 49.